A Phase I dose-escalation study of afatinib combined with nintedanib in patients with advanced solid tumors.
Future Oncol
; 11(10): 1479-91, 2015.
Article
in En
| MEDLINE
| ID: mdl-25963426
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Antineoplastic Combined Chemotherapy Protocols
/
Neoplasms
Type of study:
Clinical_trials
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Future Oncol
Year:
2015
Document type:
Article
Affiliation country:
Country of publication: